Simcere Pharmaceutical Group Limited (FRA:S2P)
Germany flag Germany · Delayed Price · Currency is EUR
1.430
-0.080 (-5.30%)
Last updated: Jul 30, 2025

Accolade Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
3,4132,1952,0393,7102,6642,462
Upgrade
Market Cap Growth
7.63%7.63%-45.02%39.23%8.23%-
Upgrade
Enterprise Value
3,3271,9451,8773,5252,6172,829
Upgrade
Last Close Price
1.330.810.731.280.89-
Upgrade
PE Ratio
35.1822.6322.3729.3812.7729.36
Upgrade
PS Ratio
3.892.502.424.323.854.36
Upgrade
PB Ratio
3.652.352.213.832.983.68
Upgrade
P/TBV Ratio
4.372.812.514.163.103.89
Upgrade
P/FCF Ratio
24.9416.04-27.04--
Upgrade
P/OCF Ratio
18.5411.93105.8320.19-203.24
Upgrade
EV/Sales Ratio
4.272.222.234.113.785.01
Upgrade
EV/EBITDA Ratio
19.7310.8315.9031.8644.7629.79
Upgrade
EV/EBIT Ratio
24.9512.9720.6942.8581.0337.66
Upgrade
EV/FCF Ratio
24.3114.21-25.69--
Upgrade
Debt / Equity Ratio
0.170.170.200.210.250.62
Upgrade
Debt / EBITDA Ratio
0.840.841.431.723.504.10
Upgrade
Debt / FCF Ratio
1.171.17-1.49--
Upgrade
Asset Turnover
0.590.590.610.600.470.51
Upgrade
Inventory Turnover
1.801.802.844.013.592.94
Upgrade
Quick Ratio
1.731.731.761.691.511.48
Upgrade
Current Ratio
2.002.002.101.841.631.85
Upgrade
Return on Equity (ROE)
10.26%10.26%9.94%13.62%25.41%19.49%
Upgrade
Return on Assets (ROA)
6.33%6.33%4.11%3.62%1.38%4.23%
Upgrade
Return on Capital (ROIC)
8.37%8.37%5.13%4.52%1.74%5.74%
Upgrade
Return on Capital Employed (ROCE)
12.90%12.90%8.70%7.80%3.30%8.10%
Upgrade
Earnings Yield
2.84%4.42%4.47%3.40%7.83%3.41%
Upgrade
FCF Yield
4.01%6.23%-2.08%3.70%-2.14%-1.30%
Upgrade
Dividend Yield
1.35%2.61%2.80%1.69%2.33%-
Upgrade
Payout Ratio
50.35%54.76%58.65%42.04%25.96%-
Upgrade
Buyback Yield / Dilution
3.40%3.40%0.45%-0.34%-9.14%-2.03%
Upgrade
Total Shareholder Return
4.83%6.01%3.25%1.34%-6.81%-2.03%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.